Glucokinase (GK) is the key enzyme controlling levels of blood glucose under normal physiological range, and GK activators are emerging class of drug candidates with promising hypoglycaemic activity. The current study was planned to design, synthesize and evaluate novel N-pyridin-2-yl benzamide analogues as allosteric activators of GK. A novel series of N-pyridin-2-yl benzamide analogues were synthesized starting from 3-nitrobenzoic acid and evaluated in vitro for GK activation followed by in silico studies to predict the binding interactions of the designed molecules with GK protein. The selected synthesized molecules (compounds 5b, 5c, 5e, 5g, 5h and 6d) which displayed excellent GK activity (GK fold activation around 2) in GK assay and appreciable binding interaction with GK in docking studies were further evaluated for their antihyperglycaemic potential using oral glucose tolerance test (OGTT) in rats. Amongst the compounds tested in vivo (OGTT assay) for antihyperglycaemic potential, compounds 5c, 5e and 5g displayed significant reduction in blood glucose levels. Compound 5e displayed most significant antidiabetic activity and comparable to that of standard drug in animal studies. The N-pyridin-2-yl benzamide analogues discovered in the current study can provide some lead molecules for the development of potent oral GK activators with minimum side-effects for the management of type 2 diabetes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/cbdd.13423 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Palladium-Mediated C(sp)-H Bond Activation of -Methyl--(pyridin-2-yl)benzamide: Direct Arylation/Alkylation and Mechanistic Investigation.
J Org Chem
July 2023
Department of Applied Science, National Taitung University, Taitung, Taiwan 95092, R.O.C.
Article Synopsis
- Researchers developed a simple method to create various -(CH-aryl/alkyl)-substituted -(pyridin-2-yl)benzamides using palladium to activate C(sp)-H bonds.
- A key intermediate, dinuclear palladacycle, was characterized using techniques like mass spectrometry and X-ray crystallography.
- The process demonstrated good versatility with functional groups and included a successful conversion of the produced compounds into -(CH-aryl)-2-aminopyridine.
Intermolecular binding preferences of haloethynyl halogen-bond donors as a function of molecular electrostatic potentials in a family of -(pyridin-2-yl)amides.
Org Biomol Chem
August 2021
Department of Chemistry, Kansas State University, 213 CBC Building, 1212 Mid-Campus Dr North, Manhattan, KS 66506 - 0401, USA.
In order to explore how σ-hole potentials, as evaluated by molecular electrostatic potential (MEP) calculations, affect the ability of halogen atoms to engage in structure-directing intermolecular interactions, we synthesized four series of ethynyl halogen-substituted amide containing pyridines (activated targets); (N-(pyridin-2-yl)benzamides (Bz-act-X), N-(pyridin-2-yl)picolinamides (2act-X), N-(pyridin-2-yl)nicotinamides (3act-X) and N-(pyridin-2-yl) isonicotinamides (4act-X), where X = Cl/Br/I. The molecules are deliberately equipped with three distinctly different halogen-bond acceptor sites, π, N(pyr), and O[double bond, length as m-dash]C, to determine binding site preferences of different halogen-bond donors. Crystallographic data for ten (out of a possible twelve) new compounds were thus analyzed and compared with data for the corresponding unactivated species.
View Article and Find Full Text PDFEstablishing Halogen-Bond Preferences in Molecules with Multiple Acceptor Sites.
Chempluschem
May 2021
Department of Chemistry, Kansas State University, 213 CBC Building, 1212 Mid-Campus Dr North, Manhattan, KS 66506-0401, USA.
The interplay between hydrogen bonds (HBs) and halogen bonds (XBs), has been addressed by co-crystallizing two halogen bond donors, 1,4-diiodotetrafluorbenzene(DITFB) and 1,3,5-trifluoro-2,4,6-triiodobenzene(TITFB) with four series of targets; N-(pyridin-2-yl)benzamide (Bz-X), N-(pyridin-2-yl)picolinamides (2Pyr-X), N-(pyridin-2-yl)nicotinamides (3Pyr-X), N-(pyridin-2-yl)isonicotinamides (4Pyr-X); X=H/Cl/Br/I. The structural outcomes were compared with interactions in the targets themselves. 13 co-crystals were analysed by single-crystal X-ray diffraction (SCXRD).
View Article and Find Full Text PDFTwo acyclic imides: 3-bromo--(3-bromo-benzo-yl)--(pyridin-2-yl)benzamide and 3-bromo--(3-bromo-benzo-yl)--(pyrimidin-2-yl)benzamide.
Acta Crystallogr E Crystallogr Commun
December 2020
School of Chemical Sciences, Dublin City University, Dublin 9, Ireland.
The title compounds, CHBrNO and CHBrNO, were synthesized in good yields from condensation reactions of 3-bromo-benzoyl chloride with 2-amino-pyridine or 2-amino-pyrimidine using standard condensation reaction conditions and subsequent column chromatography.
View Article and Find Full Text PDFN-pyridinylbenzamides: an isosteric approach towards new antimycobacterial compounds.
Chem Biol Drug Des
March 2021
Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
A series of N-pyridinylbenzamides was designed and prepared to investigate the influence of isosterism and positional isomerism on antimycobacterial activity. Comparison to previously published isosteric N-pyrazinylbenzamides was made as an attempt to draw structure-activity relationships in such type of compounds. In total, we prepared 44 different compounds, out of which fourteen had minimum inhibitory concentration (MIC) values against Mycobacterium tuberculosis H37Ra below 31.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!